The global burden of disease 2000 project: aims, methods and data sources

CJL Murray

2001-01-01

Abstract:1. ObjectivesDecision makers need the best available evidence in the form of quantities of interest to them. Concerns about quality and uncertainty of data are not an acceptable reason for failing to provide such evidence, as decisions must be made now and decision makers will not wait years for improvements in evidence before making these decisions. This means systematically identifying and assembling all the relevant evidence available now, assessing its quality, limitations and uncertainty, and using the best possible methods to come up with estimates of the quantities of interest to decision makers, with estimates of the uncertainty in these. In relation to international efforts to improve the health of populations, this means assessing the available evidence, and using the best available methods, to quantify the burden of disease and injury, its causes in terms of risk factors and broader health determinants, and the likely burden in the future. The Global Burden of Disease (GBD) project was formed to address these objectives. As well generating the most comprehensive and consistent set of estimates of mortality and morbidity by age, sex and region ever produced (1-7), the GBD also introduced a new metric–disability adjusted life year (DALY)–to quantify the burden of disease (4). The DALY is a health gap measure, which combines information on the impact of premature death and of disability and other non-fatal health outcomes. One DALY can be thought of as one lost year of ‘healthy’life and the burden of disease as a measurement of the gap between current health status and an ideal situation where everyone lives into old age free of …